Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Year-over-year SG&A expense growth
Latest
23.90%
↑ 2610% vs avg
Percentile
P87
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
0.88%
Historical baseline
| Period | Value |
|---|---|
| Q1 2023 | 23.90% |
| Q4 2022 | 36.73% |
| Q3 2022 | -11.96% |
| Q2 2022 | -4.91% |
| Q1 2022 | -47.75% |
| Q4 2021 | 54.30% |
| Q3 2021 | -18.15% |
| Q2 2021 | 4.48% |
| Q1 2021 | -8.84% |
| Q4 2020 | 3.88% |
| Q3 2020 | 2.52% |
| Q2 2020 | -0.34% |
| Q1 2020 | -1.80% |
| Q4 2019 | 14.77% |
| Q3 2019 | -23.82% |
| Q2 2019 | 8.01% |
| Q1 2019 | -31.56% |
| Q4 2018 | 17.49% |
| Q3 2018 | -15.41% |
| Q2 2018 | -2.71% |
| Q1 2018 | -17.49% |
| Q4 2017 | 54.74% |
| Q3 2017 | 10.36% |
| Q2 2017 | -8.06% |
| Q1 2017 | 1.68% |
| Q4 2016 | -5.99% |
| Q3 2016 | -29.53% |
| Q2 2016 | 25.76% |
| Q1 2016 | 3.51% |
| Q4 2015 | 9.31% |
| Q3 2015 | -13.93% |
| Q2 2015 | -3.36% |
| Q1 2015 | -4.70% |
| Q4 2014 | 1.49% |
| Q3 2014 | -5.02% |
| Q2 2014 | 8.53% |
| Q1 2014 | -8.99% |
| Q4 2013 | -11.34% |
| Q3 2013 | 28.17% |
| Q2 2013 | 1.26% |